SCHEMBL10179377

SCHEMBL10179377

Nc1cc(-c2cccc(NCC3CCCCC3)n2)c(Cl)cn1

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 20/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12827079 1.00 CCNT1 (0.70) CCNT1
SCHEMBL1463033 0.89 CCNT1 (0.68) CCNT1
SCHEMBL1946520 0.87 CCNT1 (0.55) CCNT1
SCHEMBL1192607 0.83 CCNT1 (0.54) CCNT1
SCHEMBL12889668 0.83 CCNT1 (1.00) CCNT1
SCHEMBL12889467 0.83 CCNT1 (1.00) CCNT1
SCHEMBL1462699 0.82 CCNT1 (0.55) CCNT1
SCHEMBL12889593 0.82 CCNT1 (1.00) CCNT1
SCHEMBL1463721 0.82 CCNT1 (0.55) CCNT1
SCHEMBL1947398 0.82 CCNT1 (0.55) CCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012101063-A1 N-ACYL PYRIDINE BIARYL COMPOUNDS AND THEIR USES NOVARTIS AG (CH) 2012-08-02 WO disclosed
WO-2012101064-A1 N-ACYL PYRIMIDINE BIARYL COMPOUNDS AS PROTEIN KINASE INHIBITORS NOVARTIS AG (CH) 2012-08-02 WO disclosed
WO-2012101062-A1 SUBSTITUTED BI-HETEROARYL COMPOUNDS AS CDK9 INHIBITORS AND THEIR USES NOVARTIS AG (CH) 2012-08-02 WO disclosed
EP-2473499-A1 BIPYRIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES Novartis AG (CH) 2012-07-11 EP disclosed
WO-2011026911-A1 BIPYRIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES NOVARTIS AG (CH) 2011-03-10 WO disclosed